Item 2.02 - Results of Operations and Financial Condition: The filing reports STERIS plc's financial results and operational performance for the period ended February 4, 2026 Item 9.01 - Financial Statements and Exhibits: The filing includes financial statements and exhibits related to the company's results of operations Company Information: STERIS plc is an Ireland-incorporated company (formerly…

Our analysis rates this filing NEUTRAL. STERIS demonstrates solid operational execution with earnings growth outpacing revenue growth, indicating margin expansion despite acknowledged headwinds. The company is managing inflationary and tariff pressures effectively through pricing discipline and…

Concern level: MODERATE (3.8/10). Key factors: Tariff headwinds explicitly identified by CEO as material earnings offset despite strong 9% revenue growth; Labor and energy cost pressures in AST segment partially offsetting operational improvements; Margin expansion being constrained by inflationary cost pressures, though company maintaining pricing discipline.

Notable risk changes: Tariff costs explicitly identified by CEO as material headwind to earnings growth despite strong 9% revenue growth and 8% organic growth; Company maintaining full fiscal 2026 guidance despite tariff and inflation pressures, indicating confidence in ability to manage through cost challenges; Strong cash flow generation ($737.6M free cash flow YTD vs $588.1M prior year) and earnings growth ($2.53…

The model predicts STE will underperform the S&P 500 by about 0.0% over 30 days (model confidence 85%). This is model analysis for research, not investment advice.